bioRxivCell BiologyPreprint
IPF AT2 cells are stuck in transition and biophysically dysfunctional
Andrey KrivoyiD, Daniel Sevilla-SáncheziD, Ian T. StanciliD, Evgenia DobrinskikhiD, Seyedeh Zahra Fotook KiaeiiD, Rachel Z. BlumhageniD, E. Erin Smith, Ivana V. YangiD, Carlyne D. CooliD, Lior AtiaiD, David A. SchwartziD
Abstract
Idiopathic Pulmonary Fibrosis (IPF) is an incurable disease with extensive molecular, cellular, and organ level dysfunction. A major gap in IPF research is the lack of understanding of how short-term cellular behavior causes long-term tissue remodeling. By optimizing lung slices from explanted human lungs, we discovered foci of migratory non-canonical alveolar type 2 (AT2) cells in regions of established lung fibrosis and found that these cells are trapped in states of cellular transition that are driven by persistent developmental repair programs. Consistent with these biophysical behaviors, pharmacological activation of {beta}-catenin reproduced persistent migration, whereas YAP activation restrained it. We conclude that imbalanced developmental programs drive AT2 cell motility and lesion heterogeneity, providing a mechanistic link between short-term cellular dynamics and slowly progressive fibrosis of IPF.
- organism: human
- research focus: cell type annotation
- research focus: cell signaling & trafficking
- research focus: development & morphogenesis
- research focus: cancer & tumor microenvironment
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Alveolar Epithelial Cell Loss of the Mitochondrial Regulator TFAM Drives Progressive Lung Fibrosis
Qianjiang Hu, Ugochi Onwuka, … Mélanie Königshoff·bioRxiv·Jul 18, 2026
- Cellular profiling identifies an early profibrotic alveolar type 2 cell signature in lung fibrosis
Ram Prasad Naikawadi, Alexey V. Bazarov, … Paul J. Wolters·American Journal of Respiratory and Critical Care MedicinePeer-reviewed·Feb 4, 2026
- YAP/TAZ activation in fibroblasts coordinates fibrotic remodeling, fibroinflammation, and epithelial dysfunction in pulmonary fibrosis
Masum M. Mia, Ashwatthaman Selvan, … Manvendra Kumar Singh·bioRxiv·Jun 23, 2025
- Sustained Yap/Taz activation promotes aberrant alveolar epithelial cell differentiation and drives persistent fibrotic remodeling
Isabella P. Gaona, A. Scott McCall, … Jason J. Gokey·JCI InsightPeer-reviewed·Jun 9, 2026
- Impaired AMPK Control of Alveolar Epithelial Cell Metabolism Promotes Pulmonary Fibrosis
L. Raposo Rodríguez, Konstantinos–Dionysios Alysandratos, … Michael Francis Beers·JCI InsightPeer-reviewed·Jul 1, 2025
- Senescence of alveolar stem cells drives progressive pulmonary fibrosis
C. Yao, X. Guan, … B. R. Stripp·bioRxiv·Nov 18, 2019